Autologous bone marrow mononuclear cell transplantation in patients with decompensated alcoholic liver disease: a randomized controlled trial

Spahr, Laurent François Joséph; Chalandon, Yves; Terraz, Sylvain; Kindler, Vincent Lucien; Rubbia-Brandt, Laura; Frossard, Jean-Louis; Breguet, Romain; Lanthier, Nicolas; Farina, Annarita; Passweg, Jakob; Becker, Christoph; Hadengue, Antoine

doi:10.1371/journal.pone.0053719

Scientific article

English

Autologous bone marrow mononuclear cell transplantation in patients with decompensated alcoholic liver disease: a randomized controlled trial

ContributorsSpahr, Laurent François Joséph; Chalandon, Yves

; Terraz, Sylvain; Kindler, Vincent Lucien; Rubbia-Brandt, Laura; Frossard, Jean-Louis; Breguet, Romain; Lanthier, Nicolas; Farina, Annarita; Passweg, Jakob; Becker, Christoph; Hadengue, Antoine

Published inPloS one, vol. 8, no. 1, e53719

Publication date2013

Abstract

Impaired liver regeneration is associated with a poor outcome in patients with decompensated alcoholic liver disease (ALD). We assessed whether autologous bone marrow mononuclear cell transplantation (BMMCT) improved liver function in decompensated ALD.

Affiliation entities

Research groups

Citation (ISO format)

SPAHR, Laurent François Joséph et al. Autologous bone marrow mononuclear cell transplantation in patients with decompensated alcoholic liver disease: a randomized controlled trial. In: PloS one, 2013, vol. 8, n° 1, p. e53719. doi: 10.1371/journal.pone.0053719

Article (Published version)

CC BY

Identifiers

PID : unige:27542
DOI : 10.1371/journal.pone.0053719
PMID : 23341981

Journal ISSN1932-6203

778views

296downloads

Creation26/03/2013 10:45:00

First validation26/03/2013 10:45:00

Update03/02/2025 08:57:26

Status update03/02/2025 08:57:26

Last indexation03/02/2025 08:59:09

Archive ouverte UNIGE

Autologous bone marrow mononuclear cell transplantation in patients with decompensated alcoholic liver disease: a randomized controlled trial

Impaired liver regeneration is associated with a poor outcome in patients with decompensated alcoholic liver disease (ALD). We assessed whether autologous bone marrow mononuclear cell transplantation (BMMCT) improved liver function in decompensated ALD.

Technical informations